@article{02644d65df2b423d85ce46432a05da00,
title = "A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia",
author = "Byrd, \{John C.\} and Pagel, \{John M.\} and Awan, \{Farrukh T.\} and Andres Forero and Flinn, \{Ian W.\} and Deauna-Limayo, \{Delva P.\} and Spurgeon, \{Stephen E.\} and Andritsos, \{Leslie A.\} and Gopal, \{Ajay K.\} and Leonard, \{John P.\} and Eisenfeld, \{Amy J.\} and Bannink, \{Jeannette E.\} and Stromatt, \{Scott C.\} and Furman, \{Richard R.\}",
note = "John C. Byrd, 1 John M. Pagel, 2 Farrukh T. Awan, 3 Andres Forero, 4 Ian W. Flinn, 5 Delva P. Deauna-Limayo, 6 Stephen E. Spurgeon, 7 Leslie A. Andritsos, 1 Ajay K. Gopal, 2 John P. Leonard, 8 Amy J. Eisenfeld, 9 Jeannette E. Bannink, 9 Scott C.",
year = "2014",
month = feb,
day = "27",
doi = "10.1182/BLOOD-2013-07-512137",
language = "American English",
volume = "123",
journal = "Blood",
publisher = "American Society of Hematology",
number = "9",
}